Phospholipid, arachidonate and eicosanoid signaling in schizophrenia
This paper reviews the potential role of arachidonic acid in the pathophysiology of schizophrenia. We discuss how abnormal levels of arachidonic acid may arise, and how dysregulation of signaling molecules derived from it have the potential to disrupt not only dopamine signaling, but numerous other...
Main Authors: | Messamore Erik, Yao Jeffrey K. |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2016-01-01
|
Series: | Oilseeds and fats, crops and lipids |
Subjects: | |
Online Access: | http://dx.doi.org/10.1051/ocl/2015054 |
Similar Items
-
Phospholipid Arachidonic Acid Remodeling During Phagocytosis in Mouse Peritoneal Macrophages
by: Luis Gil-de-Gómez, et al.
Published: (2020-08-01) -
Editorial: Eicosanoids in Cancer
by: Nune Markosyan, et al.
Published: (2021-09-01) -
Cellular Plasmalogen Content Does Not Influence Arachidonic Acid Levels or Distribution in Macrophages: A Role for Cytosolic Phospholipase A<sub>2</sub>γ in Phospholipid Remodeling
by: Patricia Lebrero, et al.
Published: (2019-07-01) -
Essential Role for Ethanolamine Plasmalogen Hydrolysis in Bacterial Lipopolysaccharide Priming of Macrophages for Enhanced Arachidonic Acid Release
by: Luis Gil-de-Gómez, et al.
Published: (2017-09-01) -
Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase
by: Jorge H. Capdevila, et al.
Published: (2000-02-01)